The long-term antiproteinuric effect of eplerenone, a selective aldosterone blocker, in patients with non-diabetic chronic kidney disease
Introduction : There is still insufficient data concerning the clinical effects of eplerenone, a selective aldosterone blocker, in patients with non-diabetic chronic kidney disease (CKD). Methods : This study included non-diabetic CKD patients with urinary protein excretion (UPE) of 1.0 g/gCr or mor...
Main Authors: | Nobuo Tsuboi, Tetsuya Kawamura, Hideo Okonogi, Takeo Ishii, Tatsuo Hosoya |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publications
2012-03-01
|
Series: | Journal of the Renin-Angiotensin-Aldosterone System |
Online Access: | https://doi.org/10.1177/1470320311412811 |
Similar Items
-
Moderate antiproteinuric effect of add-on aldosterone blockade with eplerenone in non-diabetic chronic kidney disease. A randomized cross-over study.
by: Lene Boesby, et al.
Published: (2011-01-01) -
A high sodium intake reduces antiproteinuric response to renin–angiotensin–aldosterone system blockade in kidney transplant recipients
by: Elena Monfá, et al.
Published: (2016-09-01) -
Eplerenone inhibits aldosterone-induced renal expression of cyclooxygenase
by: MA Bayorh, et al.
Published: (2012-09-01) -
Eplerenone suppresses aldosterone/ salt-induced expression of NOX-4
by: Mohamed A Bayorh, et al.
Published: (2011-09-01) -
Effects of eplerenone on cerebral aldosterone levels and brain lesions in spontaneously hypertensive rats
by: Xue Wang, et al.
Published: (2020-08-01)